GNE-9605 - CAS 1536200-31-3
Catalog number:
1536200-31-3
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
LRRK2
Description:
GNE-9605 retained excellent predicted human metabolic stability when assayed in human liver microsomes and hepatocytes. In addition, no reversible or time-dependent inhibition of any of the major CYP isoforms was observed. The demonstrated metabolic stability, brain penetration across multiple species, and selectivity of these inhibitors support their use in preclinical efficacy and safety studies.
Publictions citing BOC Sciences Products
  • >> More
Purity:
0.98
Appearance:
white to off-white solid powder
Synonyms:
GNE9605; GNE 9605
MSDS:
Inquire
1.Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors.
Estrada AA1, Chan BK, Baker-Glenn C, Beresford A, Burdick DJ, Chambers M, Chen H, Dominguez SL, Dotson J, Drummond J, Flagella M, Fuji R, Gill A, Halladay J, Harris SF, Heffron TP, Kleinheinz T, Lee DW, Le Pichon CE, Liu X, Lyssikatos JP, Medhurst AD, Mof J Med Chem. 2014 Feb 13;57(3):921-36. doi: 10.1021/jm401654j. Epub 2014 Jan 15.
Leucine-rich repeat kinase 2 (LRRK2) has drawn significant interest in the neuroscience research community because it is one of the most compelling targets for a potential disease-modifying Parkinson's disease therapy. Herein, we disclose structurally diverse small molecule inhibitors suitable for assessing the implications of sustained in vivo LRRK2 inhibition. Using previously reported aminopyrazole 2 as a lead molecule, we were able to engineer structural modifications in the solvent-exposed region of the ATP-binding site that significantly improve human hepatocyte stability, rat free brain exposure, and CYP inhibition and induction liabilities. Disciplined application of established optimal CNS design parameters culminated in the rapid identification of GNE-0877 (11) and GNE-9605 (20) as highly potent and selective LRRK2 inhibitors. The demonstrated metabolic stability, brain penetration across multiple species, and selectivity of these inhibitors support their use in preclinical efficacy and safety studies.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related LRRK2 Products


CAS 1351761-44-8 GNE-7915

GNE-7915
(CAS: 1351761-44-8)

CAS 1536200-31-3 GNE-9605

GNE-9605
(CAS: 1536200-31-3)

GNE-9605 retained excellent predicted human metabolic stability when assayed in human liver microsomes and hepatocytes. In addition, no reversible or time-depen...

JH-II-127
(CAS: 1700693-08-8)

JH-II-127, a Pyrrolopyrimidine derivative, is a highly potent, selective, and brain penetrant LRRK2 inhibitor, of both wild-type and G2019S mutant LRRK2. IC50: ...

CAS 1191911-27-9 CZC-54252

CZC-54252
(CAS: 1191911-27-9)

Potent inhibitor of leucine-rich repeat kinase 2 (LRRK2) (IC50 values are 1.28 nM and 1.85 nM for wild-type and G2019S mutant forms of LRRK2 respectively). Atte...

CAS 1234480-84-2 LRRK2-IN-1

LRRK2-IN-1
(CAS: 1234480-84-2)

LRRK2-IN-1 is a benzodiazepine based derivative and is known as a selective inhibitor of the Parkinson's disease kinase LRRK2.

CAS 1374828-69-9 GNE-0877

GNE-0877
(CAS: 1374828-69-9)

CAS 1527473-33-1 PF-06447475

PF-06447475
(CAS: 1527473-33-1)

PF06447475 is a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitor. Leucine rich repeat kinase 2 (LRRK2) has been genetically ...

CAS 1627091-47-7 MLi-2

MLi-2
(CAS: 1627091-47-7)

MLi-2 is a potent, orally available and brain penetrant inhibitor of LRRK2 (IC50= 0.76 nM) with excellent selectivity that shows >295-fold selectivity for over ...

CAS 1330003-04-7 CZC-25146 hydrochloride

CZC-25146 hydrochloride
(CAS: 1330003-04-7)

CZC-25146 is a compound that acts as an inhibitor of LRRK2, a factor in the expression of Parkinsons’s disease, and is ATP-competitive.

CAS 1351758-81-0 HG-10-102-01

HG-10-102-01
(CAS: 1351758-81-0)

HG-10-102-01 is a potent and selective inhibitor of wild-type LRRK2(IC50=23.3 nM) and the G2019S mutant(IC50=3.2 nM)<br /> <strong>IC50 Value</strong>: 23.3 nM ...

CAS 1285515-21-0 GSK2578215A

GSK2578215A
(CAS: 1285515-21-0)

GSK2578215A induces a dose-dependent inhibition of Ser910 and Ser935 phosphorylation in both wild-type LRRK2 and LRRK2[G2019S] stably transfected into HEK293 ce...

CAS 1191911-26-8 CZC-25146

CZC-25146
(CAS: 1191911-26-8)

CZC-25146 is a compound that acts as an inhibitor of LRRK2, a factor in the expression of Parkinsons

Chemical Structure

CAS 1536200-31-3 GNE-9605

Quick Inquiry

Verification code

Featured Items